A VALVE SPECIFICALLY DESIGNED FOR A PULMONIC INDICATION
The Melody transcatheter pulmonary valve (TPV) was the first transcatheter valve commercially approved. Since 2006, it has benefited more than 15,000 patients globally. TPV replacement with the Melody valve has proven to be a safe and effective treatment for patients with post-operative right ventricular outflow tract (RVOT) conduit or surgical valve dysfunction.
The Melody TPV is a less-invasive approach that has been proven to:
Relieve conduit and surgical valve obstruction
Restore valve function
Delay the patient’s next surgical intervention
The Melody TPV is indicated for use in the management of pediatric and adult patients who have a clinical indication for intervention on a dysfunctional RVOT conduit or surgical bioprosthetic pulmonary valve that has ≥ moderate regurgitation, and/or a mean RVOT gradient ≥35 mmHg.
MELODY VALVE: OPTIMAL HEMODYNAMICS FOR THE RVOT
Comprised of a bovine jugular vein (BJV) valve sutured within a platinum iridium frame, the Melody valve is specifically designed to treat RVOT valve dysfunction.
Natural thin leaflets open and close under minimal pressure for optimal hemodynamics in the low pressure RVOT.
Deep coaptation of leaflets provides valve competency across a range of conduit sizes and geometries, including non-circular environments.
Radiopaque stent allows for visualization ease.
Consistent outcomes with excellent performance at more than 7 years of patient follow-up.